Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04776356
Other study ID # AIRR-0012
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date May 25, 2021
Est. completion date June 29, 2023

Study information

Verified date August 2023
Source Arthrex GmbH
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The prospective, post-market, single-center clinical study will include 45 subjects who are candidates for surgery using the Arthrex QuickFix Small Staple for Akin osteotomy to correct hallux valgus interphalangeus. The purpose of the study is to evaluate the continued safety and effectiveness of the device. Device-related adverse events as well as patient reported outcomes (VAS, FFI, FAAM, VR-12) will be collected up to 1 year postoperative.


Recruitment information / eligibility

Status Terminated
Enrollment 12
Est. completion date June 29, 2023
Est. primary completion date June 29, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Subject requires surgery using the Arthrex QuickFix Small Staple for Akin osteotomy. 2. Subject is 18 years of age or older. 3. Subject is not considered a vulnerable subject (i.e. child, pregnant, nursing, prisoner, or ward of the state). 4. Subject signed informed consent and is willing and able to comply with all study requirements. Exclusion Criteria: 1. Insufficient quantity or quality of bone. 2. Blood supply limitations and previous infections which may retard healing. 3. Foreign-body sensitivity. 4. Any active infection or blood supply limitations. 5. Conditions that tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period. 6. Subjects that are skeletally immature.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
QuickFix Small Staple (Arthrex)
The Arthrex QuickFix Small Staple enables the surgeon to perform a wedge osteotomy of the first phalanx (Akin). The device is made of stainless steel and designed with barbed leg tips. The staple sizes are 8 and 10 mm wide with a 1 mm diameter.

Locations

Country Name City State
Germany Überörtliche Gemeinschaftspraxis für Chirurgie, Unfallchirurgie, Anästhesie und Endoskopie Meissen

Sponsors (1)

Lead Sponsor Collaborator
Arthrex GmbH

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of Visual Analogue Scale (VAS) Measuring pain in the affected foot. Range 0-10 (0=best, 10=worst). preoperatively, 2 weeks, 6 week, 3 months, 6 months and 12 months postoperative
Primary Change of Foot Function Index (FFI) Measuring foot functionality. Range 0-100 (0=best, 100=worst) preoperatively, 3 months, 6 months and 12 months postoperative
Primary Change of Foot and Ankle Ability Measure (FAAM Sport) Measuring foot functionality. Range 0-100 (0=worst, 100=best) preoperatively, 3 months, 6 months and 12 months postoperative
Primary Change of Veterans RAND 12 Iteam Health Survey (VR-12) Measuring quality of life. Range 0-100 (0=worst, 100=best) preoperatively, 6 months and 12 months postoperative
See also
  Status Clinical Trial Phase
Completed NCT04284618 - Off Axis View Radiographs Assessing Hallux Valgus Interphalangeus in Hallux Valgus Deformity